Navigation Links
Viral curiosity spreads across continents

WHAT: Biologist Esteban Engel, Ph.D., was named by The Pew Charitable Trusts as the "Biomedical Researcher of the Month," for his innovative work in neurovirologythe study of viruses infecting the nervous system. As a postdoctoral researcher in the Princeton University laboratory of Lynn Enquist, Ph.D., Dr. Engel studies the spread of herpes simplex virus type 1 (HSV-1)which, in rare cases, can lead to blindness or lethal encephalitis.

Dr. Engel's story is part of a "Biomedical Researcher of the Month" series launched by Pew, and is the first to feature a Latin American fellow. Pew's Latin American fellows program gives individuals like Engel, who hails from Chile, an opportunity to further their scientific knowledge by promoting exchange and collaboration between investigators in the United States and Latin America. Since 1991, Pew's biomedical programs have provided funding to more than 200 young scientists from Latin America to receive postdoctoral training in the United States, resulting in advances that span continents.

WHO: Experts are available for interviews regarding Dr. Engel's research and the program:

  • Esteban Engel, Ph.D., postdoctoral fellow, Department of Molecular Biology, Princeton Neuroscience Institute, Princeton University
  • Anita Pepper, Ph.D., director of the Pew Programs in the Biomedical Sciences Pepper is the director of The Pew Charitable Trusts' biomedical programs, which include both the Latin American fellows and the Pew scholars program.

WHERE: Visit to read the full question-and-answer story, which covers both Dr. Engel's research and his motivation to conduct it in the United States.

CONTACT: Chelsea Toledo at 202-540-6846,


Contact: Chelsea Toledo
Pew Health Group

Related biology news :

1. Recreational use of HIV antiretroviral drug linked to its psychoactivity
2. Antiviral lipid earns patent
3. Early antiretroviral treatment reduces viral reservoirs in HIV-infected teens
4. Study: Viral reactivation a likely link between stress and heart disease
5. Protein production: Going viral
6. Viral alliances overcoming plant defenses
7. New study shows promise in using RNA nanotechnology to treat cancers and viral infections
8. The physics of going viral
9. Vitamin D supplements may protect against viral infections during the winter
10. Women & Infants participating in study of treatment of common viral infection in pregnancy
11. Discovery offers insight into treating viral stomach flu
Post Your Comments:
(Date:6/15/2016)... ALBANY, New York , June 15, 2016 ... published a new market report titled "Gesture Recognition Market ... Trends and Forecast, 2016 - 2024". According to the ... at USD 11.60 billion in 2015 and is ... and reach USD 48.56 billion by 2024.  ...
(Date:6/9/2016)... -- Paris Police Prefecture ... to ensure the safety of people and operations in several ... tournament Teleste, an international technology group specialised in ... that its video security solution will be utilised by ... safety across the country. The system roll-out is scheduled for ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... June 27, 2016  Sequenom, Inc. (NASDAQ: ... healthier lives through the development of innovative products and ... the United States denied its petition ... claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") ... established by the Supreme Court,s Mayo Collaborative Services v. ...
(Date:6/27/2016)... Chapel Hill, N.C. (PRWEB) , ... June 27, ... ... of U.S. commercial operations for Amgen, will join the faculty of the ... will serve as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... Wausau, WI (PRWEB) , ... June 23, 2016 ... ... probiotic supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, ... supplements for over 35 years, is proud to add Target to its list ...
Breaking Biology Technology: